The coronary stent market was valued at USD 8.99 billion in 2023 and is projected to reach USD 12.51 billion by 2032, growing at a steady compound annual growth rate (CAGR) of 3.6% from 2024 to 2032.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5152
Coronary stents are medical devices commonly used in angioplasty procedures to treat blocked coronary arteries caused by coronary artery disease (CAD). CAD occurs when plaque builds up in the coronary arteries, restricting blood flow to the heart, which can lead to chest pain, heart attacks, and heart failure. Stents are small, expandable mesh tubes inserted into these narrowed arteries to keep them open and improve blood circulation.
The coronary stent market emerged in the late 1980s with the introduction of balloon-expandable stents, which revolutionized the treatment of CAD. Prior to stent technology, bypass surgery was the primary treatment option, but it was invasive. Today, coronary stents are primarily used in percutaneous coronary intervention (PCI), also known as angioplasty with stenting. This minimally invasive procedure uses catheters to place stents in the blocked arteries, offering a less invasive solution to treat CAD.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/coronary-stent-market-sizing
Access exclusive insight now @ https://www.towardshealthcare.com/price/5152
We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com
Web: https://www.towardshealthcare.com
Visit Dental Specifics: https://www.towardsdental.com
Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
The U.S. AI in healthcare market, valued at USD 11.57 billion in 2025, is projected to expand to USD 194.88… Read More
The global next-generation AI in life sciences market is witnessing rapid expansion, projected to reach several hundred million USD by… Read More
The U.S. oncology pharmaceutical market is poised for substantial growth, projected to generate hundreds of millions in revenue from 2025… Read More
The global autologous cell therapy market—valued at US$ 9.6 billion in 2024 and US$ 11.41 billion in 2025—is projected to… Read More
The U.S. biotechnology market is on a high-velocity growth path — from USD 699.02 billion in 2025 to USD 2,004.86… Read More
AI in Healthcare Market is projected to grow from USD 37.98 billion in 2025 to USD 674.19 billion by 2034… Read More